Author(s):
Rohini C. Kolhe, Aarti Shivareddy
Email(s):
rohini.kolhe@gmail.com
DOI:
10.52711/2321-5844.2025.00022 
Address:
Rohini C. Kolhe1*, Aarti Shivareddy2
1Department of Pharmacognosy, JSPM’S Rajarshi Shahu College of Pharmacy and Research, Tathawade, Pune.
2Department of Pharmaceutics, JSPM’S Rajarshi Shahu College of Pharmacy and Research, Tathawade, Pune.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2025
ABSTRACT:
Cannabidiol (CBD), a non-psychoactive compound sourced from the Cannabis sativa plant, has gained significant interest in the skincare industry for its therapeutic properties. Review highlights anti-inflammatory and antioxidant properties of Cannabidiol, focusing on its role in supporting skin health. Inflammation and oxidative stress are major factors in skin issues such as acne, eczema, psoriasis, and premature aging. By interacting with the endocannabinoid system, CBD helps regulate inflammatory processes, potentially alleviating these conditions. Additionally, its potent antioxidant activity aids in neutralizing free radicals, shielding the skin from environmental aggressors like UV rays and pollution. Recent studies emphasize CBD's capacity to reduce pro-inflammatory cytokine production and combat oxidative stress, showcasing its potential in preventing and managing various skin conditions. Furthermore, its calming effects make it an ideal choice for sensitive skin, offering a natural alternative to conventional skincare ingredients. In summary, CBD shows great promise as a multifunctional ingredient in skincare, delivering both anti-inflammatory and antioxidant benefits. As interest in natural, effective skincare solutions continues to grow, further studies are needed to explore CBD's mechanisms and evaluate its long-term impact in dermatology.
Cite this article:
Rohini C. Kolhe, Aarti Shivareddy. Exploring Cannabidiol’s Therapeutic Potential in Skincare with Focus on Anti-Inflammation and Antioxidant Activity. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2):142-8. doi: 10.52711/2321-5844.2025.00022
Cite(Electronic):
Rohini C. Kolhe, Aarti Shivareddy. Exploring Cannabidiol’s Therapeutic Potential in Skincare with Focus on Anti-Inflammation and Antioxidant Activity. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2):142-8. doi: 10.52711/2321-5844.2025.00022 Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2025-16-2-12
REFERENCES:
1. Bhagwat DA, Patil ND, Patel GS, Killedar SG, More HN. Formulation and Evaluation of Herbal Lipstick using Lycopene Extracted from Solanum lycopersicum L. Research J. Pharm. and Tech. 2017; 10(4): 1060-1064.
2. Vaidiyanathan. R, Anand B, Importance of Chemistry in Herbal Cosmetics and Cosmeceuticals. Research J. Pharm. and Tech 2017; 10(12): 4460-4462.
3. Saklani S, Prashar D, Sharma D. An Economical Overview on Herbal Cosmetics. Res. J. Topical and Cosmetic Sci. 2012; 3(1): 4-10.
4. Chandrasekar R, A Comprehensive Review on Herbal Cosmetics in the Management of Skin Diseases. Research J. Topical and Cosmetic Sci. 2020; 11(1):32-44.
5. Syal S, Pandit V, Ashawat MS. Traditional Herbs to treat Acne Vulgaris. Asian J. Pharm. Res. 2020; 10(3): 195-201.
6. Gulhane SA, Sawale AV, Padmawar S. Formulation and Evaluation of Herbal Antiaging cream of Insulin plant. Research Journal of Science and Technology. 2024; 16(1):1-5.
7. Gite SS., Jadhav AJ., Zalte AG., Saudagar RB. A Review on Oils used in Herbal Cosmetics. Res. J. Topical and Cosmetic Sci. 2013; 4(1): 61-64.
8. Garg A. Herbs in Cosmetics: An Overview. Research Journal of Topical and Cosmetic Sciences. 2023; 14(1): 45-9. doi: 10.52711/2321-5844.2023.00007.
9. Avhad PD, Ippar AS, Shaikh HS. Herbs used in Skin Care Cosmetics: A Systemic Review. Research Journal of Topical and Cosmetic Sciences. 2024; 15(2): 117-4.
10. Saklani S, Prashar D, Sharma D. An Economical Overview on Herbal Cosmetics. Res. J. Topical and Cosmetic Sci. 2012; 3(1): 4-10.
11. Baswan SM, Klosner AE, Glynn K, Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. ClinCosmetInvestig Dermatol. 2020; 13: 927-942. Published 2020 Dec 8. doi:10.2147/CCID.S286411
12. Lee S, Lee Y, Kim Y. Beneficial effects of cannabidiol from Cannabis. Applied Biological Chemistry. 2024; 67: 32. https://doi.org/10.1186/s13765-024-00867-w
13. Voicu V, Brehar FM, Toader C, Covache-Busuioc RA, Corlatescu AD, Bordeianu A, Costin HP, Bratu BG, Glavan LA, Ciurea AV. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules. 2023; 13(9): 1388. https://doi.org/10.3390/biom13091388
14. Lu HC, Mackie K. An Introduction to the Endogenous Cannabinoid System. Biol Psychiatry. 2016; 79(7): 516-525. doi:10.1016/j.biopsych.2015.07.028
15. Dasram MH, Walker RB, Khamanga SM. Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery. Int J Mol Sci. 2022; 23(21): 13223. Published 2022 Oct 30. doi:10.3390/ijms232113223
16. Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol. 2006; 147(S1): S163–S171.
17. Mounessa JS, Siegel JA, Dunnick CA, Dellavalle RP. The role of cannabinoids in dermatology. J Am Acad Dermatol. 2017; 77(1): 188–190.
18. Bietar B, Tanner S, Lehmann C. Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. Int J Mol Sci. 2023; 24(23): 16728. Published 2023 Nov 24. doi:10.3390/ijms242316728
19. Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. 2009; 30(8): 411-420. doi:10.1016/j.tips.2009.05.004
20. Zouboulis CC, Coenye T, He L, Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations. Front Immunol. 2022; 13:1029818. Published 2022 Nov 10. doi:10.3389/fimmu.2022.1029818
21. Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. Molecules. 2019; 24(5): 918. https://doi.org/10.3390/molecules24050918
22. Zou S, Kumar U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int J Mol Sci. 2018; 19(3): 833. Published 2018 Mar 13. doi:10.3390/ijms19030833
23. Hossain KR, Alghalayini A, Valenzuela SM. Current Challenges and Opportunities for Improved Cannabidiol Solubility. Int J Mol Sci. 2023; 24(19): 14514. Published 2023 Sep 25. doi:10.3390/ijms241914514
24. Mnekin L, Ripoll L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics. 2021; 8(3): 85. https://doi.org/10.3390/cosmetics8030085
25. Blebea NM, Pricopie AI, Vlad RA, Hancu G. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. International Journal of Molecular Sciences. 2024; 25(8): 4204. https://doi.org/10.3390/ijms25084204
26. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008; 153(2): 199-215. doi:10.1038/sj.bjp.0707442
27. Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free RadicBiol Med. 2011; 51(5): 1054-1061. doi:10.1016/j.freeradbiomed.2011.01.007
28. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017; 2: 17023-. doi:10.1038/sigtrans.2017.23
29. Anand U, Jones B, Korchev Y, et al. CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. J Pain Res. 2020; 13: 2269-2278. Published 2020 Sep 11. doi:10.2147/JPR.S258433
30. Rosenbaum T, Simon SA. TRPV1 Receptors and Signal Transduction. In: Liedtke WB, Heller S, editors. TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. Boca Raton (FL): CRC Press/Taylor and Francis; 2007. Chapter 5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK5260/
31. Leweke FM, Piomelli D, Pahlisch F, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012; 2(3): e94. Published 2012 Mar 20. doi:10.1038/tp.2012.15
32. Ahn K, Johnson DS, Cravatt BF. Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov. 2009; 4(7): 763-784. doi:10.1517/17460440903018857
33. Casares L, García V, Garrido-Rodríguez M, Millán E, Collado JA, García-Martín A, Peñarando J, Calzado MA, Vega L, Muñoz E, Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1, Redox Biology. 2020; 28: 101321
34. Martinez Naya N, Kelly J, Corna G, Golino M, Abbate A, Toldo S. Molecular and Cellular Mechanisms of Action of Cannabidiol. Molecules. 2023; 28(16): 5980. Published 2023 Aug 9. doi:10.3390/molecules28165980
35. Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. Int J Mol Sci. 2023; 24(4): 3125. Published 2023 Feb 4. doi:10.3390/ijms24043125
36. Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol. 2008; 3: 279-312. doi:10.1146/annurev. pathmechdis.3.121806.151409
37. Peltner LK, Gluthmann L, Börner F, Pace S, Hoffstetter RK, Jordan PM, Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators, 2023; 30(12): 1508-1524.
38. Yan G, Zhang X, Li H, Guo Y, Yong VW, Xue M. Anti-oxidant effects of cannabidiol relevant to intracerebral hemorrhage. Front Pharmacol. 2023; 14: 1247550. Published 2023 Sep 28. doi:10.3389/fphar.2023.1247550
39. Pereira SR, Hackett B, O'Driscoll DN, Sun MC, Downer EJ.Cannabidiol modulation of oxidative stress and signalling. Neuronal Signal. 2021; 5(3): NS20200080. Published 2021 Aug24.doi:10.1042/NS20200080
40. Kletkiewicz H, Wojciechowski MS, Rogalska J. Cannabidiol effectively prevents oxidative stress and stabilizes hypoxia-inducible factor-1 alpha (HIF-1α) in an animal model of global hypoxia. Sci Rep. 2024; 14(1): 15952. Published 2024 Jul 10. doi:10.1038/s41598-024-66599-5
41. Jîtcă G, Ősz BE, Vari CE, Rusz CM, Tero-Vescan A, Pușcaș A. Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants (Basel). 2023; 12(2): 485. Published 2023 Feb 14. doi:10.3390/antiox12020485
42. Atalay S, Dobrzyńska I, Gęgotek A, Skrzydlewska E. Cannabidiol protects keratinocyte cell membranes following exposure to UVB and hydrogen peroxide. Redox Biol. 2020; 36: 101613. doi:10.1016/j.redox.2020.101613
43. Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014; 2014: 360438. doi:10.1155/2014/360438
44. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev PharmacolToxicol. 2013; 53: 401-426. doi:10.1146/annurev-pharmtox-011112-140320
45. Aziz N, Jamil RT. Biochemistry, Xanthine Oxidase. [Updated 2023 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545245/
46. Ryan MJ, Jackson JR, Hao Y, Leonard SS, Alway SE. Inhibition of xanthine oxidase reduces oxidative stress and improves skeletal muscle function in response to electrically stimulated isometric contractions in aged mice. Free RadicBiol Med. 2011; 51(1): 38-52. doi:10.1016/j.freeradbiomed.2011.04.002
47. Chan JZ, Duncan RE. Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review. Cells. 2021; 10(5): 1251. Published 2021 May 19. doi:10.3390/cells10051251
48. Ferreira, B.P., Costa, G., Mascarenhas-Melo, F. et al. Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety. Phytochem Rev. 2023; 22: 781–828. https://doi.org/10.1007/s11101-023-09860-5
49. Baker P, Huang C, Radi R, Moll SB, Jules E, Arbiser JL. Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties. Cells. 2023; 12(23): 2745. Published 2023 Nov 30. doi:10.3390/cells12232745
50. Alexander H, Brown S, Danby S, Flohr C. Research Techniques Made Simple: Transepidermal Water Loss Measurement as a Research Tool. J Invest Dermatol. 2018 Nov; 138(11): 2295-2300.e1. doi: 10.1016/j.jid.2018.09.001. PMID: 30348333.
51. Makhakhe L. Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities. S AfrFamPract (2004). 2022; 64(1): e1-e4. Published 2022 May 30. doi:10.4102/safp.v64i1.5493
52. Martins AM, Gomes AL, Vilas Boas I, Marto J, Ribeiro HM. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review [published correction appears in Pharmaceuticals (Basel). 2022 Jul 11; 15(7): 849. doi: 10.3390/ph15070849]. Pharmaceuticals (Basel). 2022; 15(2): 210. Published 2022 Feb 9. doi:10.3390/ph15020210
53. Filipiuc S-I, Neagu A-N, Uritu CM, Tamba B-I, Filipiuc L-E, Tudorancea IM, Boca AN, Hâncu MF, Porumb V, Bild W. The Skin and Natural Cannabinoids–Topical and Transdermal Applications. Pharmaceuticals. 2023; 16(7): 1049. https://doi.org/10.3390/ph16071049
54. Oláh, A.; Toth, B.; Borbíró, I.; Sugawara, K.; Szöllõsi, A.; Czifra, G.; Pal, B.; Ambrus, L.; Hundt, J.; Camera, E.; et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J. Clin. Investig. 2014; 124: 3713–3724.